NICE (NASDAQ:NICE – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 10.950-11.150 for the period, compared to the consensus estimate of 10.730. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.
NICE Stock Performance
Shares of NICE stock opened at $199.17 on Thursday. The stock’s 50-day moving average price is $172.27 and its 200 day moving average price is $178.68. NICE has a 52-week low of $151.52 and a 52-week high of $270.73. The stock has a market capitalization of $12.52 billion, a PE ratio of 33.25, a price-to-earnings-growth ratio of 1.56 and a beta of 1.04. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.13.
NICE (NASDAQ:NICE – Get Free Report) last posted its quarterly earnings data on Thursday, August 15th. The technology company reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. NICE had a net margin of 15.55% and a return on equity of 14.68%. The firm had revenue of $664.40 million for the quarter, compared to analyst estimates of $664.10 million. During the same period last year, the firm posted $1.63 EPS. NICE’s quarterly revenue was up 14.3% on a year-over-year basis. As a group, equities research analysts forecast that NICE will post 8.5 EPS for the current year.
Analysts Set New Price Targets
Check Out Our Latest Report on NICE
About NICE
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Recommended Stories
- Five stocks we like better than NICE
- Retail Stocks Investing, Explained
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- What Are the U.K. Market Holidays? How to Invest and Trade
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.